TP53 and neoplasm: Consistent with this hypothesis, the frequency of TP53 mutation in pT1G2 tumours, although higher than that in pTa tumours (18% versus 7%), was found to be much lower than that reported in cases of dysplasia or CIS tumours (65–72%) [3], [17].